Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi Wen

Showing results (681-690 of 692) with videos related to

Pageof 70
Sort By:
Frontiers in Oncology|January 31, 2022
Factors Predicting Oncological Outcomes of Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma in TaiwanI-Hsuan Alan Chen, Chao-Hsiang Chang, Chi-Ping Huang, et al.
Frontiers in Oncology|May 9, 2022
Impact of Adjuvant Chemotherapy on Variant Histology of Upper Tract Urothelial Carcinoma: A Propensity Score-Matched Cohort AnalysisChi-Wen Lo, Wei-Ming Li, Hung-Lung Ke, et al.
Surgical Neurology|October 13, 2009
Clinical practice guidelines in severe traumatic brain injury in TaiwanKuo-Hsing Liao, Cheng-Kuei Chang, Hong-Chang Chang, et al.
Cancer Research|December 4, 2016
IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear PolaritySarah Chiang, Britta Weigelt, Huei-Chi Wen, et al.
Frontiers in Oncology|January 2, 2023
Oncologic impact of delay between diagnosis and radical nephroureterectomyKuan-Hsien Wu, Chao-Hsiang Chang, Hsi-Chin Wu, et al.
Nature Communications|May 10, 2018
Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomasFelipe C Geyer, Anqi Li, Anastasios D Papanastasiou, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2023
Development of AAV-delivered broadly neutralizing anti-human ACE2 antibodies against SARS-CoV-2 variantsCheng-Pu Sun, Chi-Wen Chiu, Ping-Yi Wu, et al.
Clinical Genitourinary Cancer|July 23, 2025
The Influence of Chronic Kidney Disease on the Management of Upper Urinary Tract Cancer Following Radical Nephroureterectomy: A Nationwide Multi-Institutional StudyChih-Chin Yu, Steven K Huang, Wen-Hsin Tseng, et al.
Scientific Reports|August 12, 2025
Cytoreductive nephroureterectomy for treatment of upper urinary tract urothelial carcinoma initially diagnosed as node-positiveShu-Yu Wu, Chi-Ping Huang, Chao-Hsiang Chang, et al.
Frontiers in Oncology|March 13, 2023
Preoperative hydronephrosis is an independent protective factor of renal function decline after nephroureterectomy for upper tract urothelial carcinomaPai-Yu Cheng, Hsiang-Ying Lee, Wei-Ming Li, et al.
Pageof 70

Showing results (681-690 of 692) with videos related to

Sort By:
Pageof 70
Frontiers in Oncology|January 31, 2022
Factors Predicting Oncological Outcomes of Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma in TaiwanI-Hsuan Alan Chen, Chao-Hsiang Chang, Chi-Ping Huang, et al.
Frontiers in Oncology|May 9, 2022
Impact of Adjuvant Chemotherapy on Variant Histology of Upper Tract Urothelial Carcinoma: A Propensity Score-Matched Cohort AnalysisChi-Wen Lo, Wei-Ming Li, Hung-Lung Ke, et al.
Surgical Neurology|October 13, 2009
Clinical practice guidelines in severe traumatic brain injury in TaiwanKuo-Hsing Liao, Cheng-Kuei Chang, Hong-Chang Chang, et al.
Cancer Research|December 4, 2016
IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear PolaritySarah Chiang, Britta Weigelt, Huei-Chi Wen, et al.
Frontiers in Oncology|January 2, 2023
Oncologic impact of delay between diagnosis and radical nephroureterectomyKuan-Hsien Wu, Chao-Hsiang Chang, Hsi-Chin Wu, et al.
Nature Communications|May 10, 2018
Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomasFelipe C Geyer, Anqi Li, Anastasios D Papanastasiou, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2023
Development of AAV-delivered broadly neutralizing anti-human ACE2 antibodies against SARS-CoV-2 variantsCheng-Pu Sun, Chi-Wen Chiu, Ping-Yi Wu, et al.
Clinical Genitourinary Cancer|July 23, 2025
The Influence of Chronic Kidney Disease on the Management of Upper Urinary Tract Cancer Following Radical Nephroureterectomy: A Nationwide Multi-Institutional StudyChih-Chin Yu, Steven K Huang, Wen-Hsin Tseng, et al.
Scientific Reports|August 12, 2025
Cytoreductive nephroureterectomy for treatment of upper urinary tract urothelial carcinoma initially diagnosed as node-positiveShu-Yu Wu, Chi-Ping Huang, Chao-Hsiang Chang, et al.
Frontiers in Oncology|March 13, 2023
Preoperative hydronephrosis is an independent protective factor of renal function decline after nephroureterectomy for upper tract urothelial carcinomaPai-Yu Cheng, Hsiang-Ying Lee, Wei-Ming Li, et al.
Pageof 70